• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于组织芯片数字分析的喉鳞状细胞癌中PTEN表达的失调

Deregulation of PTEN Expression in Laryngeal Squamous Cell Carcinoma Based on Tissue Microarray Digital Analysis.

作者信息

Mastronikolis Nicholas S, Tsiambas Evangelos, Papadas Theodoros A, Karameris Andreas, Ragos Vasileios, Peschos Dimitrios, Mastronikolis Stylianos N, Papadas Athanasios T, Liatsos Christos, Armata Ilianna E, Fotiades Panagiotis P

机构信息

ENT Department, Medical School, University of Patras, Patras, Greece.

Department of Immunohistochemistry & Molecular Biology, 401 GAH, Athens, Greece

出版信息

Anticancer Res. 2017 Oct;37(10):5521-5524. doi: 10.21873/anticanres.11983.

DOI:10.21873/anticanres.11983
PMID:28982865
Abstract

BACKGROUND/AIM: Phosphatase and tensin homolog (PTEN) (gene locus: 10q23.3) -a tumor suppressor gene- is deleted, mutated or epigenetically hyper-methylated in a variety of malignancies. PTEN acts as a negative regulator in PI3K/AKT/mTOR signaling transduction pathway. Our aim was to investigate PTEN protein expression patterns in laryngeal squamous cell carcinomas (LSCC).

MATERIALS AND METHODS

Using tissue microarray technology, fifty (n=50) primary LSCCs were cored and re-embedded into one recipient block. Immunohistochemistry and digital image analysis were implemented for evaluating protein expression levels.

RESULTS

Abnormal protein expression (low to negative staining intensity values) was observed in 28/50 (56%) tissue cores. Overall PTEN expression was associated with the anatomical region of the malignancies (p=0.039), whereas a borderline correlation with the differentiation grade was also assessed (p=0.05).

CONCLUSION

Aberrant expression of PTEN tumor-suppressor gene in LSCCs seems to affect their biological behavior. Well-differentiated tumors express moderate to high protein levels, an evidence of normal gene function, whereas loss of its expression correlates with a progressive tumor dedifferentiation. Additionally, loss of its expression is detected more frequently in specific anatomical regions of the larynx (glottis, predominantly, and partially supraglottis).

摘要

背景/目的:磷酸酶和张力蛋白同源物(PTEN)(基因座:10q23.3)——一种肿瘤抑制基因——在多种恶性肿瘤中存在缺失、突变或表观遗传高甲基化。PTEN在PI3K/AKT/mTOR信号转导通路中起负调节作用。我们的目的是研究喉鳞状细胞癌(LSCC)中PTEN蛋白的表达模式。

材料与方法

采用组织芯片技术,从50例原发性LSCC中获取组织芯并重新包埋于一个受体块中。采用免疫组织化学和数字图像分析评估蛋白表达水平。

结果

在50个组织芯中的28个(56%)观察到异常蛋白表达(低至阴性染色强度值)。总体PTEN表达与恶性肿瘤的解剖区域相关(p = 0.039),同时也评估了与分化程度的临界相关性(p = 0.05)。

结论

LSCC中PTEN肿瘤抑制基因的异常表达似乎影响其生物学行为。高分化肿瘤表达中等至高蛋白质水平,这是基因功能正常的证据,而其表达缺失与肿瘤的逐渐去分化相关。此外,在喉的特定解剖区域(主要是声门和部分声门上区)更频繁地检测到其表达缺失。

相似文献

1
Deregulation of PTEN Expression in Laryngeal Squamous Cell Carcinoma Based on Tissue Microarray Digital Analysis.基于组织芯片数字分析的喉鳞状细胞癌中PTEN表达的失调
Anticancer Res. 2017 Oct;37(10):5521-5524. doi: 10.21873/anticanres.11983.
2
Determination of matrix metalloproteinase 9 (MMP-9) protein expression in laryngeal squamous cell carcinomas based on digital image analysis.基于数字图像分析的喉鳞状细胞癌中基质金属蛋白酶9(MMP - 9)蛋白表达的测定
J BUON. 2013 Oct-Dec;18(4):977-81.
3
MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.微小RNA 744-3p通过同时抑制喉鳞状细胞癌中的PDCD4和PTEN促进基质金属蛋白酶-9介导的转移。
Oncotarget. 2016 Sep 6;7(36):58218-58233. doi: 10.18632/oncotarget.11280.
4
Topoisomerase I deregulation in laryngeal squamous cell carcinomas based on tissue microarray analysis.基于组织芯片分析的喉鳞状细胞癌中拓扑异构酶I的失调
J BUON. 2017 May-Jun;22(3):771-776.
5
Expression of PTEN protein in patients with laryngeal squamous cell carcinoma.喉鳞状细胞癌患者中PTEN蛋白的表达
Auris Nasus Larynx. 2007 Dec;34(4):481-6. doi: 10.1016/j.anl.2007.03.014. Epub 2007 May 1.
6
Poor prognostic clinicopathologic features correlate with VEGF expression but not with PTEN expression in squamous cell carcinoma of the larynx.在喉鳞状细胞癌中,不良预后的临床病理特征与 VEGF 表达相关,但与 PTEN 表达无关。
Diagn Pathol. 2010 Jun 14;5:35. doi: 10.1186/1746-1596-5-35.
7
Altered expression of miR-21 and PTEN in human laryngeal and hypopharyngeal squamous cell carcinomas.miR-21和PTEN在人喉及下咽鳞状细胞癌中的表达改变
Asian Pac J Cancer Prev. 2011;12(10):2653-7.
8
Full-length spleen tyrosine kinase inhibits the invasion and metastasis of human laryngeal squamous cell carcinoma.全长脾酪氨酸激酶抑制人喉鳞状细胞癌的侵袭和转移。
Int J Clin Exp Pathol. 2015 Dec 1;8(12):15786-93. eCollection 2015.
9
Aurora kinase A revives dormant laryngeal squamous cell carcinoma cells via FAK/PI3K/Akt pathway activation.极光激酶A通过激活FAK/PI3K/Akt信号通路使休眠的喉鳞状细胞癌细胞复苏。
Oncotarget. 2016 Jul 26;7(30):48346-48359. doi: 10.18632/oncotarget.10233.
10
Cyclin D1 Gene Numerical Imbalances in Laryngeal Squamous Cell Carcinoma: A Tissue Microarray Grid Based Analysis.喉鳞状细胞癌中细胞周期蛋白D1基因的数值失衡:基于组织微阵列网格的分析
Asian Pac J Cancer Prev. 2020 Feb 1;21(2):379-384. doi: 10.31557/APJCP.2020.21.2.379.

引用本文的文献

1
Metabolic reprogramming and immune microenvironment characteristics in laryngeal carcinoma: advances in immunotherapy.喉癌中的代谢重编程与免疫微环境特征:免疫治疗进展
Front Immunol. 2025 Apr 30;16:1589243. doi: 10.3389/fimmu.2025.1589243. eCollection 2025.
2
Laryngeal sarcomatoid carcinoma: a case report and literature review on potential molecular targets for therapeutic opportunities.喉肉瘤样癌:一例报告及治疗机会潜在分子靶点的文献综述
Front Oncol. 2025 Mar 31;15:1549790. doi: 10.3389/fonc.2025.1549790. eCollection 2025.
3
p-mTOR, p-ERK and PTEN Expression in Tumor Biopsies and Organoids as Predictive Biomarkers for Patients with HPV Negative Head and Neck Cancer.
肿瘤组织活检和类器官中 p-mTOR、p-ERK 和 PTEN 的表达作为 HPV 阴性头颈部癌症患者的预测性生物标志物。
Head Neck Pathol. 2023 Sep;17(3):697-707. doi: 10.1007/s12105-023-01576-4. Epub 2023 Jul 24.
4
To Study the Role of PTEN, EGFR and HER2 in Early Glottic Squamous Cell Carcinoma.研究PTEN、表皮生长因子受体(EGFR)和人表皮生长因子受体2(HER2)在早期声门鳞状细胞癌中的作用。
Indian J Otolaryngol Head Neck Surg. 2023 Jun;75(2):707-712. doi: 10.1007/s12070-022-03455-w. Epub 2023 Jan 6.
5
p53 and PTEN expression evaluation with molecular evident recent criteria in laryngeal carcinoma.用分子学最新标准评估喉癌中的 p53 和 PTEN 表达。
Medicine (Baltimore). 2023 May 12;102(19):e33676. doi: 10.1097/MD.0000000000033676.
6
Non-Targeted Serum Lipidomics Analysis and Potential Biomarkers of Laryngeal Cancer Based on UHPLC-QTOF-MS.基于超高效液相色谱-四极杆飞行时间质谱的喉癌非靶向血清脂质组学分析及潜在生物标志物
Metabolites. 2022 Nov 9;12(11):1087. doi: 10.3390/metabo12111087.
7
Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem.喉癌分子生物标志物概述:探寻一个老问题的新答案
Cancers (Basel). 2022 Mar 28;14(7):1716. doi: 10.3390/cancers14071716.
8
Association of epidermal growth factor receptor protein expression with histopathological and clinical parameters in carcinoma of the larynx.表皮生长因子受体蛋白表达与喉癌组织病理学及临床参数的相关性
Transl Cancer Res. 2019 Aug;8(4):1395-1402. doi: 10.21037/tcr.2019.07.26.
9
Hsa_circ_0006232 promotes laryngeal squamous cell cancer progression through FUS-mediated EZH2 stabilization.Hsa_circ_0006232 通过 FUS 介导的 EZH2 稳定促进喉鳞状细胞癌进展。
Cell Cycle. 2021 Sep;20(18):1799-1811. doi: 10.1080/15384101.2021.1959973. Epub 2021 Aug 26.
10
Any Role of PIK3CA and PTEN Biomarkers in the Prognosis in Oral Squamous Cell Carcinoma?PIK3CA和PTEN生物标志物在口腔鳞状细胞癌预后中起作用吗?
Life (Basel). 2020 Dec 3;10(12):325. doi: 10.3390/life10120325.